GSK, Perrigo and Teva recall products; GSK facility affected in China explosion;

> A GlaxoSmithKline ($GSK) plant was among the many facilities affected by an explosion in a chemical warehouse last week in China's Tianjin port. Story

> Perrigo recalls 158,268 tubes of mometasone furoate ointment. Recall

> GlaxoSmithKline has recalled 17,675 cases of its OTC Panadol acetaminophen that failed dissolution specifications. Recall

> Recro Pharma says the contract manufacturing business it bought from Alkermes ($ALKS) has helped its revenue picture. Release

> Bausch and Stroebel, a German maker of custom pharma packaging equipment, is building a new plant in Brandford, CT. Report

> Teva ($TEVA) has recalled 19,504 bottles of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate tablets after an unknown impurity was found during testing. Report

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.